

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.32412259 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.32412259 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.32412259 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.32412259 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.32412259 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.32412259 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.36183104 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.78363889 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 4.64081061 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.58157548 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 4.47244004 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.39067867 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.33906111 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.33906111 |
| 15 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.33687700 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.26698665 |
| 17 | response to host immune response (GO:0052572) | 4.13104388 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.13104388 |
| 19 | detection of other organism (GO:0098543) | 4.11811175 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 4.02654557 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.01821980 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.96652480 |
| 23 | response to peptidoglycan (GO:0032494) | 3.95814866 |
| 24 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.83086410 |
| 25 | response to host (GO:0075136) | 3.83086410 |
| 26 | response to host defenses (GO:0052200) | 3.83086410 |
| 27 | detection of bacterium (GO:0016045) | 3.81153314 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.80700798 |
| 29 | detection of external biotic stimulus (GO:0098581) | 3.74103656 |
| 30 | respiratory burst (GO:0045730) | 3.72449345 |
| 31 | microglial cell activation (GO:0001774) | 3.62834500 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51353650 |
| 33 | T-helper 1 type immune response (GO:0042088) | 3.45050718 |
| 34 | B cell receptor signaling pathway (GO:0050853) | 3.36857429 |
| 35 | response to protozoan (GO:0001562) | 3.35767413 |
| 36 | regulation of cholesterol storage (GO:0010885) | 3.34622954 |
| 37 | detection of biotic stimulus (GO:0009595) | 3.33985296 |
| 38 | regulation of B cell differentiation (GO:0045577) | 3.30742871 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.30630461 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.30354848 |
| 41 | cellular extravasation (GO:0045123) | 3.30114516 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 3.29912220 |
| 43 | macrophage activation (GO:0042116) | 3.28139523 |
| 44 | positive regulation of interferon-beta production (GO:0032728) | 3.26569924 |
| 45 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.23541527 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.21772760 |
| 47 | response to muramyl dipeptide (GO:0032495) | 3.19926975 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.17841971 |
| 49 | I-kappaB phosphorylation (GO:0007252) | 3.17536887 |
| 50 | positive regulation of type 2 immune response (GO:0002830) | 3.11563670 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11269452 |
| 52 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10890085 |
| 53 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.10887487 |
| 54 | low-density lipoprotein particle clearance (GO:0034383) | 3.10682529 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06081737 |
| 56 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.05850106 |
| 57 | regulation of mast cell activation (GO:0033003) | 3.03911169 |
| 58 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.03491740 |
| 59 | granulocyte activation (GO:0036230) | 3.02592049 |
| 60 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.01018900 |
| 61 | negative regulation of cell killing (GO:0031342) | 3.01018900 |
| 62 | cellular response to ethanol (GO:0071361) | 3.00975034 |
| 63 | neutrophil activation (GO:0042119) | 3.00702495 |
| 64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99661703 |
| 65 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.97825273 |
| 66 | response to type I interferon (GO:0034340) | 2.97588822 |
| 67 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95398500 |
| 68 | type I interferon signaling pathway (GO:0060337) | 2.95321192 |
| 69 | cellular response to type I interferon (GO:0071357) | 2.95321192 |
| 70 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.94825486 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94336971 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 2.94142237 |
| 73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.94034160 |
| 74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91761479 |
| 75 | positive thymic T cell selection (GO:0045059) | 2.91622275 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 2.89340464 |
| 77 | protein carboxylation (GO:0018214) | 2.87766071 |
| 78 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.87766071 |
| 79 | B cell mediated immunity (GO:0019724) | 2.87714045 |
| 80 | negative regulation of interleukin-17 production (GO:0032700) | 2.87217226 |
| 81 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.86927615 |
| 82 | regulation of leukocyte degranulation (GO:0043300) | 2.86515670 |
| 83 | regulation of interleukin-12 production (GO:0032655) | 2.86371966 |
| 84 | pinocytosis (GO:0006907) | 2.86256362 |
| 85 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.85734038 |
| 86 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.84098095 |
| 87 | regulation of superoxide anion generation (GO:0032928) | 2.81666196 |
| 88 | myeloid dendritic cell differentiation (GO:0043011) | 2.81409579 |
| 89 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.80525414 |
| 90 | cellular response to interferon-gamma (GO:0071346) | 2.79785932 |
| 91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79697051 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.79653023 |
| 93 | germinal center formation (GO:0002467) | 2.79131738 |
| 94 | myeloid leukocyte activation (GO:0002274) | 2.77120912 |
| 95 | negative regulation of interleukin-12 production (GO:0032695) | 2.76247130 |
| 96 | regulation of tolerance induction (GO:0002643) | 2.74992182 |
| 97 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74356499 |
| 98 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74223945 |
| 99 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.73472299 |
| 100 | natural killer cell mediated immunity (GO:0002228) | 2.73472299 |
| 101 | regulation of mast cell degranulation (GO:0043304) | 2.70708351 |
| 102 | neutrophil mediated immunity (GO:0002446) | 2.70191479 |
| 103 | regulation of T cell tolerance induction (GO:0002664) | 2.69962131 |
| 104 | regulation of antigen processing and presentation (GO:0002577) | 2.69606486 |
| 105 | negative regulation of lipid storage (GO:0010888) | 2.68351408 |
| 106 | defense response to protozoan (GO:0042832) | 2.67923606 |
| 107 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.66817088 |
| 108 | complement activation, alternative pathway (GO:0006957) | 2.63722804 |
| 109 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.63142043 |
| 110 | phospholipid homeostasis (GO:0055091) | 2.61805827 |
| 111 | leukocyte aggregation (GO:0070486) | 2.61744572 |
| 112 | NIK/NF-kappaB signaling (GO:0038061) | 2.61351097 |
| 113 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59804613 |
| 114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.59516903 |
| 115 | positive regulation of mast cell activation (GO:0033005) | 2.58583503 |
| 116 | detection of molecule of bacterial origin (GO:0032490) | 2.58205474 |
| 117 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.57212303 |
| 118 | positive regulation of humoral immune response (GO:0002922) | 2.53998483 |
| 119 | apoptotic cell clearance (GO:0043277) | 2.53769610 |
| 120 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.53654357 |
| 121 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.53620538 |
| 122 | regulation of interferon-beta production (GO:0032648) | 2.52997530 |
| 123 | tolerance induction (GO:0002507) | 2.52132594 |
| 124 | T cell migration (GO:0072678) | 2.51971015 |
| 125 | negative regulation of interleukin-6 production (GO:0032715) | 2.51300492 |
| 126 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.50611178 |
| 127 | urea metabolic process (GO:0019627) | 2.50547770 |
| 128 | urea cycle (GO:0000050) | 2.50547770 |
| 129 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.45641747 |
| 130 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.45129683 |
| 131 | positive regulation of mast cell degranulation (GO:0043306) | 2.45129683 |
| 132 | mature B cell differentiation (GO:0002335) | 2.44968584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.97145330 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.15059395 |
| 3 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.99640189 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.83605323 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.67831553 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.32743214 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.29145007 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.28437890 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.12147612 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10764798 |
| 11 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.03099333 |
| 12 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.90750085 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.86576208 |
| 14 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.84586312 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.83434079 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.82353615 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.71312053 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70366539 |
| 19 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.51430081 |
| 20 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50644185 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.45402711 |
| 22 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.35485775 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.28563759 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25402588 |
| 25 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23820338 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18480864 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15903490 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12854169 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98006370 |
| 30 | * MYC_22102868_ChIP-Seq_BL_Human | 1.94927983 |
| 31 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.91380772 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90750091 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.89870761 |
| 34 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88999971 |
| 35 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.88828050 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87954191 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87087874 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.86954986 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82265613 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80372896 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.78769398 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74325895 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.72748395 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72630842 |
| 45 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68403903 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.66221570 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.62596223 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61373297 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60014525 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55536436 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54228112 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51130735 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50740558 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49384361 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48612590 |
| 56 | * GATA1_22025678_ChIP-Seq_K562_Human | 1.45168337 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41706629 |
| 58 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39129100 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35268565 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34033188 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32388148 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30769699 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29741580 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28796268 |
| 65 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28693920 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26640956 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25193899 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17054124 |
| 69 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15662697 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14769125 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14689321 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10492691 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09832966 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09439720 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09233324 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09220574 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.08755127 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08562284 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08459221 |
| 80 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06673018 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05856211 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04881428 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03292806 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02812227 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02657191 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00421592 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99612454 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98037480 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98009789 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97124955 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95753554 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94597511 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94073642 |
| 94 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93685533 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91535401 |
| 96 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91344768 |
| 97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87840872 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86989495 |
| 99 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84916005 |
| 100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83348534 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82528657 |
| 102 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81926892 |
| 103 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.81286806 |
| 104 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79190559 |
| 105 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.78994529 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77922681 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76928606 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75658916 |
| 109 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.75508940 |
| 110 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.75043000 |
| 111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75017974 |
| 112 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74176302 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72899821 |
| 114 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71820657 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71657600 |
| 116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.70153672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.68021650 |
| 2 | MP0003303_peritoneal_inflammation | 3.51624172 |
| 3 | MP0009840_abnormal_foam_cell | 3.23930308 |
| 4 | MP0003436_decreased_susceptibility_to | 3.08053595 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.87095386 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.84028435 |
| 7 | MP0001790_abnormal_immune_system | 2.74537182 |
| 8 | MP0005387_immune_system_phenotype | 2.74537182 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.65926610 |
| 10 | MP0009785_altered_susceptibility_to | 2.61778509 |
| 11 | MP0002419_abnormal_innate_immunity | 2.60515840 |
| 12 | * MP0001800_abnormal_humoral_immune | 2.59879445 |
| 13 | MP0006082_CNS_inflammation | 2.55166276 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.47651768 |
| 15 | MP0000685_abnormal_immune_system | 2.45199273 |
| 16 | MP0005360_urolithiasis | 2.43520765 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.37800085 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.36534845 |
| 19 | MP0005025_abnormal_response_to | 2.35230505 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.26052950 |
| 21 | * MP0002723_abnormal_immune_serum | 2.19517486 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.19221719 |
| 23 | MP0004510_myositis | 2.17930720 |
| 24 | MP0005671_abnormal_response_to | 2.09636640 |
| 25 | MP0005083_abnormal_biliary_tract | 2.02326318 |
| 26 | MP0005365_abnormal_bile_salt | 1.97013357 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.94454844 |
| 28 | * MP0002420_abnormal_adaptive_immunity | 1.93195601 |
| 29 | * MP0001819_abnormal_immune_cell | 1.93050736 |
| 30 | MP0004947_skin_inflammation | 1.88017877 |
| 31 | MP0003724_increased_susceptibility_to | 1.79017518 |
| 32 | MP0005085_abnormal_gallbladder_physiolo | 1.75586589 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.72473230 |
| 34 | MP0008469_abnormal_protein_level | 1.71096613 |
| 35 | MP0009278_abnormal_bone_marrow | 1.71022153 |
| 36 | MP0000604_amyloidosis | 1.69771562 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.69256230 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.65905604 |
| 39 | MP0002405_respiratory_system_inflammati | 1.62630417 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.56221609 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.54759565 |
| 42 | * MP0000716_abnormal_immune_system | 1.51947500 |
| 43 | * MP0000689_abnormal_spleen_morphology | 1.50353262 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.49789419 |
| 45 | MP0001853_heart_inflammation | 1.48635944 |
| 46 | * MP0002398_abnormal_bone_marrow | 1.48338791 |
| 47 | MP0009764_decreased_sensitivity_to | 1.48241950 |
| 48 | MP0003252_abnormal_bile_duct | 1.46451452 |
| 49 | MP0008260_abnormal_autophagy | 1.44555809 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.41909096 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.41529308 |
| 52 | MP0000609_abnormal_liver_physiology | 1.38952044 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.36136395 |
| 54 | * MP0002722_abnormal_immune_system | 1.25592324 |
| 55 | MP0003075_altered_response_to | 1.25339187 |
| 56 | * MP0002429_abnormal_blood_cell | 1.24725285 |
| 57 | MP0003690_abnormal_glial_cell | 1.21696601 |
| 58 | MP0003828_pulmonary_edema | 1.21404265 |
| 59 | MP0003448_altered_tumor_morphology | 1.21121441 |
| 60 | MP0001873_stomach_inflammation | 1.19789177 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.17601949 |
| 62 | MP0009763_increased_sensitivity_to | 1.17506329 |
| 63 | MP0004883_abnormal_blood_vessel | 1.15981625 |
| 64 | MP0000343_altered_response_to | 1.15815241 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.14998466 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.14998466 |
| 67 | MP0010307_abnormal_tumor_latency | 1.12690654 |
| 68 | MP0002132_abnormal_respiratory_system | 1.12567969 |
| 69 | MP0005310_abnormal_salivary_gland | 1.10067999 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.06675810 |
| 71 | MP0005076_abnormal_cell_differentiation | 1.05743497 |
| 72 | MP0005166_decreased_susceptibility_to | 1.05370155 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.04266806 |
| 74 | MP0002006_tumorigenesis | 1.03632831 |
| 75 | MP0008004_abnormal_stomach_pH | 1.03570288 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.02674057 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.01250935 |
| 78 | MP0001666_abnormal_nutrient_absorption | 1.01184415 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.98290529 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.97761989 |
| 81 | MP0003866_abnormal_defecation | 0.94937020 |
| 82 | MP0000598_abnormal_liver_morphology | 0.94462598 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.94433329 |
| 84 | MP0002396_abnormal_hematopoietic_system | 0.91924053 |
| 85 | MP0002933_joint_inflammation | 0.91562023 |
| 86 | MP0001851_eye_inflammation | 0.90532988 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 0.87938151 |
| 88 | MP0002254_reproductive_system_inflammat | 0.85602205 |
| 89 | MP0005174_abnormal_tail_pigmentation | 0.84186167 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83866252 |
| 91 | MP0000858_altered_metastatic_potential | 0.83604268 |
| 92 | MP0003091_abnormal_cell_migration | 0.83193383 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.81858403 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.81675497 |
| 95 | MP0003195_calcinosis | 0.81545254 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.79803513 |
| 97 | MP0005451_abnormal_body_composition | 0.79717263 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 0.79708687 |
| 99 | MP0003763_abnormal_thymus_physiology | 0.79663740 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.79120242 |
| 101 | MP0002928_abnormal_bile_duct | 0.78821683 |
| 102 | MP0001663_abnormal_digestive_system | 0.78756855 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.77752904 |
| 104 | MP0005332_abnormal_amino_acid | 0.74716202 |
| 105 | MP0000249_abnormal_blood_vessel | 0.74693092 |
| 106 | MP0003806_abnormal_nucleotide_metabolis | 0.74110820 |
| 107 | MP0005023_abnormal_wound_healing | 0.71844807 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.70329385 |
| 109 | MP0000703_abnormal_thymus_morphology | 0.68928024 |
| 110 | MP0003045_fibrosis | 0.67849242 |
| 111 | MP0005164_abnormal_response_to | 0.65884930 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.65089835 |
| 113 | MP0000371_diluted_coat_color | 0.64952786 |
| 114 | MP0008873_increased_physiological_sensi | 0.64792625 |
| 115 | MP0008874_decreased_physiological_sensi | 0.64030903 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.63204107 |
| 117 | MP0005390_skeleton_phenotype | 0.63046327 |
| 118 | MP0000920_abnormal_myelination | 0.62710347 |
| 119 | MP0004381_abnormal_hair_follicle | 0.62474450 |
| 120 | MP0003795_abnormal_bone_structure | 0.61401104 |
| 121 | MP0006054_spinal_hemorrhage | 0.60898676 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59069701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.29948907 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.06999726 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.93755408 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.74059140 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.41943862 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 4.11288676 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.87643171 |
| 8 | T lymphocytopenia (HP:0005403) | 3.78617735 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.75614758 |
| 10 | Complement deficiency (HP:0004431) | 3.68231096 |
| 11 | Myocardial infarction (HP:0001658) | 3.62513980 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.49829901 |
| 13 | Abnormality of T cell number (HP:0011839) | 3.49583525 |
| 14 | Glomerulonephritis (HP:0000099) | 3.47787365 |
| 15 | Cellulitis (HP:0100658) | 3.41468846 |
| 16 | Joint hemorrhage (HP:0005261) | 3.40771210 |
| 17 | Recurrent skin infections (HP:0001581) | 3.40575909 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.30998402 |
| 19 | Colitis (HP:0002583) | 3.30500401 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.30431900 |
| 21 | Recurrent viral infections (HP:0004429) | 3.26176843 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.24729758 |
| 23 | Myositis (HP:0100614) | 3.23742665 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.23375030 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 3.21538728 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.19947873 |
| 27 | Encephalitis (HP:0002383) | 3.17261175 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.14443736 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.14186046 |
| 30 | Deep venous thrombosis (HP:0002625) | 3.13330795 |
| 31 | Abnormality of complement system (HP:0005339) | 3.04633593 |
| 32 | Vasculitis (HP:0002633) | 3.04086116 |
| 33 | Keratoconjunctivitis (HP:0001096) | 3.03123367 |
| 34 | Dysostosis multiplex (HP:0000943) | 3.02218379 |
| 35 | Orchitis (HP:0100796) | 3.01195608 |
| 36 | Hemoptysis (HP:0002105) | 2.95092373 |
| 37 | Chronic otitis media (HP:0000389) | 2.88795643 |
| 38 | Xanthomatosis (HP:0000991) | 2.88782060 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.87206065 |
| 40 | Agammaglobulinemia (HP:0004432) | 2.84817249 |
| 41 | Gingivitis (HP:0000230) | 2.84164890 |
| 42 | Gingival bleeding (HP:0000225) | 2.81656406 |
| 43 | Meningitis (HP:0001287) | 2.79614335 |
| 44 | Periodontitis (HP:0000704) | 2.78378534 |
| 45 | Stomatitis (HP:0010280) | 2.76139198 |
| 46 | Abnormality of B cell number (HP:0010975) | 2.75923417 |
| 47 | Osteomyelitis (HP:0002754) | 2.75581578 |
| 48 | Gastrointestinal inflammation (HP:0004386) | 2.75323072 |
| 49 | B lymphocytopenia (HP:0010976) | 2.72323587 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.66794722 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.66794722 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66324175 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66324175 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66324175 |
| 55 | Amyloidosis (HP:0011034) | 2.64343637 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.63287952 |
| 57 | Optic neuritis (HP:0100653) | 2.63287952 |
| 58 | Hematochezia (HP:0002573) | 2.61765283 |
| 59 | Abnormality of T cells (HP:0002843) | 2.61391869 |
| 60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60838820 |
| 61 | Obstructive lung disease (HP:0006536) | 2.60838820 |
| 62 | Axonal loss (HP:0003447) | 2.58681995 |
| 63 | Pustule (HP:0200039) | 2.57833094 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.57747528 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.57747528 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.57747528 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.55392440 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.54103444 |
| 69 | Urticaria (HP:0001025) | 2.53423612 |
| 70 | Loss of speech (HP:0002371) | 2.52946440 |
| 71 | Mitral stenosis (HP:0001718) | 2.51947289 |
| 72 | Gangrene (HP:0100758) | 2.51520648 |
| 73 | Chest pain (HP:0100749) | 2.46053877 |
| 74 | Increased IgE level (HP:0003212) | 2.44211154 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 2.43513784 |
| 76 | Granulocytopenia (HP:0001913) | 2.41939482 |
| 77 | Abnormality of the common coagulation pathway (HP:0010990) | 2.41084778 |
| 78 | Prolonged partial thromboplastin time (HP:0003645) | 2.40782142 |
| 79 | Purpura (HP:0000979) | 2.38765309 |
| 80 | Nephritis (HP:0000123) | 2.37140979 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.37062453 |
| 82 | Arterial thrombosis (HP:0004420) | 2.36474363 |
| 83 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.36327969 |
| 84 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.35865933 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 2.35568550 |
| 86 | Intrahepatic cholestasis (HP:0001406) | 2.35045690 |
| 87 | Hypercholesterolemia (HP:0003124) | 2.33140005 |
| 88 | Eosinophilia (HP:0001880) | 2.32947729 |
| 89 | Disinhibition (HP:0000734) | 2.32571570 |
| 90 | Increased IgM level (HP:0003496) | 2.31499551 |
| 91 | Sepsis (HP:0100806) | 2.28581510 |
| 92 | IgM deficiency (HP:0002850) | 2.28532238 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.27731540 |
| 94 | Prolonged bleeding time (HP:0003010) | 2.26366886 |
| 95 | Anorexia (HP:0002039) | 2.26348766 |
| 96 | Combined immunodeficiency (HP:0005387) | 2.25443469 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.25039968 |
| 98 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24829689 |
| 99 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24829689 |
| 100 | Epistaxis (HP:0000421) | 2.23082498 |
| 101 | Pulmonary infiltrates (HP:0002113) | 2.21945437 |
| 102 | Esophageal varix (HP:0002040) | 2.20489276 |
| 103 | Nasal polyposis (HP:0100582) | 2.15398444 |
| 104 | Petechiae (HP:0000967) | 2.15299920 |
| 105 | Prostate neoplasm (HP:0100787) | 2.15280881 |
| 106 | Severe combined immunodeficiency (HP:0004430) | 2.14057294 |
| 107 | Lymphopenia (HP:0001888) | 2.12695010 |
| 108 | Abnormality of the prostate (HP:0008775) | 2.12531326 |
| 109 | Upper motor neuron abnormality (HP:0002127) | 2.12059194 |
| 110 | Leukocytosis (HP:0001974) | 2.10952989 |
| 111 | Pulmonary embolism (HP:0002204) | 2.10802227 |
| 112 | Recurrent pneumonia (HP:0006532) | 2.10310406 |
| 113 | Polyneuropathy (HP:0001271) | 2.09979850 |
| 114 | Tetraparesis (HP:0002273) | 2.08642248 |
| 115 | Restrictive lung disease (HP:0002091) | 2.08403934 |
| 116 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05510503 |
| 117 | Papilloma (HP:0012740) | 2.05315895 |
| 118 | Verrucae (HP:0200043) | 2.05315895 |
| 119 | Impaired platelet aggregation (HP:0003540) | 2.04401390 |
| 120 | Abnormal platelet function (HP:0011869) | 2.04401390 |
| 121 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.03535557 |
| 122 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.03213757 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 2.03106664 |
| 124 | Increased serum ferritin (HP:0003281) | 2.02826517 |
| 125 | Thoracic kyphosis (HP:0002942) | 2.02100418 |
| 126 | Abnormality of eosinophils (HP:0001879) | 2.01667630 |
| 127 | Thyroiditis (HP:0100646) | 2.00669568 |
| 128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99819965 |
| 129 | Abnormality of the nasal mucosa (HP:0000433) | 1.98507149 |
| 130 | Hepatosplenomegaly (HP:0001433) | 1.98212747 |
| 131 | Recurrent lower respiratory tract infections (HP:0002783) | 1.98137430 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.97332761 |
| 133 | Menorrhagia (HP:0000132) | 1.97160040 |
| 134 | Viral hepatitis (HP:0006562) | 1.97065791 |
| 135 | Emphysema (HP:0002097) | 1.97016899 |
| 136 | Thrombophlebitis (HP:0004418) | 1.92423117 |
| 137 | Pathologic fracture (HP:0002756) | 1.91997487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.06301833 |
| 2 | ERN1 | 3.98952807 |
| 3 | TYK2 | 3.25167798 |
| 4 | TBK1 | 3.07185883 |
| 5 | MAP3K14 | 2.96566360 |
| 6 | MAP3K10 | 2.86030485 |
| 7 | BLK | 2.81547490 |
| 8 | RIPK4 | 2.67261959 |
| 9 | IRAK3 | 2.57494227 |
| 10 | KIT | 2.56987996 |
| 11 | PRPF4B | 2.44586781 |
| 12 | CSF1R | 2.33110304 |
| 13 | IRAK4 | 2.27954261 |
| 14 | IKBKE | 2.20079011 |
| 15 | JAK1 | 2.03214588 |
| 16 | TGFBR2 | 2.01175328 |
| 17 | TAOK3 | 1.91406871 |
| 18 | BMPR2 | 1.90727493 |
| 19 | TRIB3 | 1.75467356 |
| 20 | CSK | 1.75307345 |
| 21 | STK10 | 1.74660896 |
| 22 | GRK6 | 1.65181731 |
| 23 | JAK3 | 1.65112772 |
| 24 | FGFR4 | 1.63394234 |
| 25 | IKBKB | 1.63378596 |
| 26 | ZAP70 | 1.63047788 |
| 27 | SYK | 1.62583586 |
| 28 | EPHB1 | 1.58515579 |
| 29 | BTK | 1.54377131 |
| 30 | FES | 1.50149670 |
| 31 | PKN2 | 1.46937903 |
| 32 | MAP3K13 | 1.46259494 |
| 33 | PIK3CG | 1.43171853 |
| 34 | HCK | 1.40165053 |
| 35 | SIK2 | 1.39782037 |
| 36 | CAMK1D | 1.27819461 |
| 37 | PTK6 | 1.25426526 |
| 38 | TAOK2 | 1.20470729 |
| 39 | SIK1 | 1.20316190 |
| 40 | LYN | 1.17394168 |
| 41 | IRAK1 | 1.16798296 |
| 42 | MAP2K3 | 1.16214095 |
| 43 | TAOK1 | 1.16005659 |
| 44 | FGR | 1.13844805 |
| 45 | CHUK | 1.13276276 |
| 46 | TNK2 | 1.12469678 |
| 47 | JAK2 | 1.12320306 |
| 48 | LCK | 1.10834428 |
| 49 | TXK | 1.10596825 |
| 50 | MATK | 1.08839983 |
| 51 | NEK9 | 1.08636183 |
| 52 | LRRK2 | 1.03928501 |
| 53 | MAP3K1 | 1.00763221 |
| 54 | CDC42BPA | 0.95760777 |
| 55 | IRAK2 | 0.94886470 |
| 56 | CDK12 | 0.91681716 |
| 57 | PIM1 | 0.88885094 |
| 58 | CAMK1G | 0.87401743 |
| 59 | RPS6KA4 | 0.85531648 |
| 60 | FGFR3 | 0.85477526 |
| 61 | ITK | 0.83849705 |
| 62 | TTN | 0.83458785 |
| 63 | FLT3 | 0.82532113 |
| 64 | MARK3 | 0.81313074 |
| 65 | CDK6 | 0.74612106 |
| 66 | TEC | 0.73235706 |
| 67 | CLK1 | 0.73068420 |
| 68 | NME2 | 0.72287361 |
| 69 | EGFR | 0.70465199 |
| 70 | RIPK1 | 0.68311579 |
| 71 | MAPK4 | 0.67242485 |
| 72 | ACVR1B | 0.67011685 |
| 73 | YES1 | 0.64494870 |
| 74 | EEF2K | 0.63306436 |
| 75 | MAP3K3 | 0.61671111 |
| 76 | KSR2 | 0.60737706 |
| 77 | CAMKK2 | 0.60533917 |
| 78 | BCKDK | 0.59481719 |
| 79 | TRPM7 | 0.58865487 |
| 80 | STK4 | 0.56379663 |
| 81 | MAPK11 | 0.55078775 |
| 82 | MOS | 0.54207466 |
| 83 | CDK4 | 0.52011400 |
| 84 | MAP3K11 | 0.51689024 |
| 85 | DDR2 | 0.50777941 |
| 86 | * ABL1 | 0.48419592 |
| 87 | PRKCQ | 0.46895043 |
| 88 | HIPK2 | 0.46823973 |
| 89 | MARK2 | 0.46653044 |
| 90 | BMX | 0.45339764 |
| 91 | PAK4 | 0.43953579 |
| 92 | PDK1 | 0.43922461 |
| 93 | MAP3K6 | 0.42293316 |
| 94 | PRKCD | 0.41335275 |
| 95 | SCYL2 | 0.40863458 |
| 96 | RPS6KA6 | 0.40108320 |
| 97 | EPHA3 | 0.39376697 |
| 98 | FYN | 0.39202101 |
| 99 | MAP3K5 | 0.39021581 |
| 100 | ABL2 | 0.37306524 |
| 101 | PIM2 | 0.36272064 |
| 102 | MAPK12 | 0.35171056 |
| 103 | PDPK1 | 0.35042010 |
| 104 | MAP3K8 | 0.34606572 |
| 105 | DYRK1B | 0.34293527 |
| 106 | KDR | 0.34239660 |
| 107 | PRKCH | 0.34126318 |
| 108 | MAP3K2 | 0.33786491 |
| 109 | SGK3 | 0.33504294 |
| 110 | STK24 | 0.32584650 |
| 111 | MAPKAPK2 | 0.32240374 |
| 112 | SIK3 | 0.31910601 |
| 113 | CDK19 | 0.31696433 |
| 114 | SMG1 | 0.31689175 |
| 115 | MAPK7 | 0.31651827 |
| 116 | RPS6KC1 | 0.30668537 |
| 117 | RPS6KL1 | 0.30668537 |
| 118 | ALK | 0.30187937 |
| 119 | MAP2K6 | 0.29731982 |
| 120 | SGK2 | 0.28624678 |
| 121 | CDK9 | 0.28235453 |
| 122 | ADRBK2 | 0.27466887 |
| 123 | NLK | 0.27285536 |
| 124 | TESK2 | 0.27170177 |
| 125 | INSR | 0.26430598 |
| 126 | PRKD2 | 0.26061623 |
| 127 | NEK2 | 0.26029875 |
| 128 | GSK3A | 0.25928097 |
| 129 | GRK7 | 0.25601943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.88351516 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.74520106 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.61707144 |
| 4 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.49585283 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.48448197 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45825559 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38819477 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.27090045 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.20881169 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15346515 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.03217378 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.00991272 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.94404555 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.86481214 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.80727479 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73045327 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.72827511 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.71406685 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.70016477 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.61679778 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59948379 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.58829476 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.58429718 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56606054 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.50943917 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49239951 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.48620818 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46858911 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.45034129 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44589218 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38759134 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34229657 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33801381 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28563674 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.27899634 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24114418 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22934340 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20721657 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.14877601 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08558091 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.05269622 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.03768043 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02873608 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.02552426 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02496879 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00979536 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99887984 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 0.97560433 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94754152 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.94666768 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94650379 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.94297675 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93670739 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 0.92811004 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89076742 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87806221 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85920255 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84972757 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84671503 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84149389 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.83314934 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82594593 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81814499 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81715147 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81153425 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.81008881 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.80625802 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.79558442 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78305218 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76091133 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75621826 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75025062 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74615851 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68957454 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.68236444 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65750242 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62648631 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61026025 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60629471 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.60224666 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59970391 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59657116 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.58150198 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56548295 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.55646962 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55434882 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.54997477 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54371015 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53909900 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53703967 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51862068 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51748048 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.51722753 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50264244 |
| 95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49370515 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48427257 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48320934 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47732550 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.47694771 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46045219 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45135922 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44104723 |
| 103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43445615 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43314782 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43093886 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42866807 |
| 107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.42767365 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42593238 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42267088 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41961129 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40364865 |
| 112 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.40350945 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39339205 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39087897 |
| 115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38454941 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38317488 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38026738 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37705802 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.33795295 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31274454 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28601105 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27038988 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26808243 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.23639024 |
| 125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22320413 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22290946 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22010252 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19042603 |
| 129 | Prostate cancer_Homo sapiens_hsa05215 | 0.17570746 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17498704 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15265608 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.14662466 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.12863253 |

